Interferon
Showing 1 - 25 of 4,547
Cervical Dysplasia, HPV Infection Trial in Ulaanbaatar (gel Interferon arm, gel Interferon and interferon suppository arm)
Recruiting
- Cervical Dysplasia
- HPV Infection
- gel Interferon arm
- gel Interferon and interferon suppository arm
-
Ulaanbaatar, MongoliaNational Cancer Center
Nov 14, 2023
Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)
Recruiting
- Polycythemia Vera
- Ruxolitinib
- Pegylated interferon α-2b
-
Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
May 19, 2023
Myeloid Leukemia, MDS Trial (IFN-?)
Not yet recruiting
- Myeloid Leukemia
- Myelodysplastic Syndromes
- (no location specified)
Nov 15, 2023
Interstitial Cystitis Trial (Interferon, Sodium Hyaluronate, Sodium Chloride Injection)
Not yet recruiting
- Interstitial Cystitis
- Interferon
- +2 more
- (no location specified)
Jun 10, 2023
CD4/CD8+ Interferon Gamma Release Assay for Monitoring
Active, not recruiting
- Tuberculosis
- Interferon gamma release assay (IGRA)
-
Milano, ItalyIRCCS San Raffaele Scientific Institute
Feb 13, 2023
HPV Infection Trial (Human interferon alpha 2b vaginal Effervescent capsules)
Not yet recruiting
- HPV Infection
- Human interferon alpha 2b vaginal Effervescent capsules
- (no location specified)
May 8, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Biopsy
- +7 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 23, 2023
Essential Thrombocytopenia Trial in Tianjin (Recombinant Interferon Alpha, Pegylated interferon alfa-2b)
Recruiting
- Essential Thrombocytopenia
- Recombinant Interferon Alpha
- Pegylated interferon alfa-2b
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Jul 18, 2022
Chronic Pulmonary Aspergillosis, Aspergillosis Trial (Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as
Not yet recruiting
- Chronic Pulmonary Aspergillosis
- Aspergillosis
- Interferon Gamma-1B 0.1 MG Per 0.5 ML Injection PLUS antifungals as standard of care
- Antifungals as standard of care
- (no location specified)
Dec 13, 2022
Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)
Not yet recruiting
- Membranous Nephropathy
- Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
-
Nice, FranceCHU de NICE
Jul 4, 2023
Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon
Active, not recruiting
- HIV
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Viral Upper Respiratory Tract Infection Trial (recombinant human interferon ? spray)
Not yet recruiting
- Viral Upper Respiratory Tract Infection
- recombinant human interferon ω spray
- (no location specified)
May 7, 2023
Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before
Not yet recruiting
- Herpes Zoster
- Recombinant Human Interferon α-2b Gel (After the Alteration)
- Recombinant Human Interferon α-2b Gel (Before the Alteration)
- (no location specified)
Apr 7, 2023
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022
Action of Interferon in Treatment of Myeloproliferative
Recruiting
- Myeloproliferative Neoplasm
-
Villejuif, Ile De France, FranceInserm U1287
Apr 28, 2023
Multiple Sclerosis Trial in Cairo (Blood sample collection)
Recruiting
- Multiple Sclerosis
- Blood sample collection
-
Cairo, EgyptNasser Institute for Research and Treatment
Feb 21, 2023
Multiple Sclerosis Trial in Shreveport (Interferon beta 1a, oral doxycycline)
Completed
- Multiple Sclerosis
- Interferon beta 1a, oral doxycycline
-
Shreveport, LouisianaLSU Health Sciences Center Shreveport
Oct 11, 2022
Pneumonia, Ventilator-Associated Trial in France (Interferon gamma, Placebo)
Not yet recruiting
- Pneumonia, Ventilator-Associated
- Interferon gamma
- Placebo
-
Lyon, France
- +6 more
May 2, 2023
Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)
Not yet recruiting
- Myelofibrosis
- Pegylated interferon alpha2a
-
Salt Lake City, UtahHuntsman Cancer Institute at the University of Utah
Sep 6, 2022
COVID-19, COVID Trial in Boston (Pegylated interferon lambda)
Terminated
- COVID-19
- COVID
- Pegylated interferon lambda
-
Boston, MassachusettsMassachusetts General Hospital
Jun 29, 2022
Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +2 more
- Cemiplimab-Rwlc
- PEG-IFN alfa-2a
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023
Melanoma Trial in Xi'an (Recombinant human interferon a1b, Toripalimab, Anlotinib HCl)
Not yet recruiting
- Melanoma
- Recombinant human interferon α1b
- +2 more
-
Xi'an, Shaanxi, ChinaAir Force Military Medical University/ Fourth Military Medical U
Sep 13, 2022
Asthma Trial in Atlanta (Albuterol Sulfate, Interferon gamma-primed mesenchymal stromal cells (MSCs), Prednisone)
Recruiting
- Asthma
- Albuterol Sulfate
- +2 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta
Jul 21, 2022
Mycobacterium Abscessus Infection in Chronic Lung Disease and
Enrolling by invitation
- Mycobacterium Abscessus Infection
- +2 more
- Appropriate treatment
-
Pathum Wan, Bangkok, ThailandKing Chulalongkorn Memorial Hospital
Aug 31, 2022
Systemic Lupus Erythematosus, Interferon Deficiency Trial in Copenhagen (High Intensity Interval Training)
Recruiting
- Systemic Lupus Erythematosus
- Interferon Deficiency
- High Intensity Interval Training
-
Copenhagen, DenmarkCenter for Physical Activity Research
Jul 26, 2022